Skip to main content
. 2021 Nov 10;3:773953. doi: 10.3389/ftox.2021.773953

FIGURE 2.

FIGURE 2

Value of the combined in vitroin vivo approach using 3D intestinal organoids and clinical trials in canine IBD patients to streamline drug research and development. Using canines with spontaneously occurring cIBD allows for minimally invasive acquisition of endoscopic biopsies to generate in vitro organoid cell culture. Organoids can be used to screen candidate treatments which then can be further evaluated in live canine patients before moving forward with human clinical trials to expedite and improve research efficiency.